The Science Advisory Board

Shape to advance RNA tech platform with $112M in new funding
Shape Therapeutics announced it raised $112 million in financing to continue building its growing portfolio of RNA technologies. Read More

NIST gives $135M to NIIMBL to bolster U.S. supply chains
The U.S. National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced it has received $153 million in new funding from the National Institute of Standards and Technology (NIST). Read More

Sana to open new CGT manufacturing facility
Sana Biotechnology has signed a lease to develop a 163,000-sq-ft manufacturing facility in Fremont, CA, to support the manufacture of its late-stage clinical development and early commercial cell and gene therapy (CGT) candidates. Read More

Forge Biologics to develop, manufacture GentiBio therapies
GentiBio and Forge Biologics have formed a strategic development and manufacturing partnership to advance GentiBio's immune tolerance platform. Read More

Cellares, Poseida partner on cell therapy manufacturing
Poseida Therapeutics has joined Cellares' Early Access Partnership Program to accelerate cell therapy manufacturing. The collaboration is expected to provide insight into CAR T workflows as well as other technologies. Read More

Lexogen offers SARS-CoV-2 workflows for variant tracing
Lexogen has validated two workflows that aim to improve SARS-CoV-2 sequencing for tracing variants of the virus. Read More

Lilly to acquire Protomer Technologies for $1B
Eli Lilly will acquire private biotechnology firm Protomer Technologies for an estimated $1 billion. Read More

Gene therapy tackles 2 rare childhood diseases 2 different ways
Two new studies point to the efficient use of gene therapy to treat deadly childhood genetic diseases. The first study used direct gene therapy infusion to treat a rare neurodevelopmental disorder, while the second study used prenatal base editing in mouse models as proof of concept for the treatment of genetic diseases. These vastly different approaches show the promise of gene therapy for a variety of devastating diseases. Read More

Prime Medicine launches with gene editing technology
Prime Medicine has launched with $315 million in financing to rapidly advance its prime editing gene editing technology. Read More